1. Heart disease and stroke statistics-2017 update: a report from the American Heart Association;Circulation,2017
2. Oral anticoagulation therapy and subsequent risk of venous thromboembolism in atrial fibrillation patients;Lutsey;Curr. Med. Res. Opin.,2018
3. Vitamin K antagonists: biochemistry, pharmacology, and management;Shan,2013
4. Overview of the new oral anticoagulants: opportunities and challenges;Yeh;Arterioscler. Thromb. Vasc. Biol.,2015
5. Direct comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in non-valvular atrial fibrillation;Noseworthy;Chest,2016